Brazil has had over 23 million cases of COVID-19 since the pandemic began, with a 97% recovery rate.
Posted on 01/24/2022 9:47:07 PM PST by SeekAndFind
The results are in from the world’s largest study of ivermectin for COVID-19.
Brazil has had over 23 million cases of COVID-19 since the pandemic began, with a 97% recovery rate.
Researchers in Brazil found that regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization and mortality rates.
The study was conducted in Itajaí, a port city in the state of Santa Catarina, between July and December 2020. Study authors include FLCCC physicians Dr. Flavio Cadegiani and Dr. Pierre Kory. Lead author Dr. Lucy Kerr was approached by the mayor of Itajaí, after the city began to experience a severe outbreak of COVID.
The entire population of Itajaí was invited to participate in the program, which involved a medical visit to compile baseline, personal, demographic, and medical information. In the absence of contraindications, ivermectin was offered as a preventative treatment, to be taken for two consecutive days every 15 days at a dose of 0.2 mg/kg/day.
Of the 223,128 citizens of Itajaí considered for the study, a total of 159,561 subjects elected to participate: over 70% opted to take ivermectin, and 23% chose not to.
The study found a 44% reduction in COVID-19 infection rate in favor of the group that took ivermectin (3.5% versus 8.2%).
In cases where a participating citizen of Itajaí became ill with COVID-19, they were recommended not to use ivermectin or any other medication in early outpatient treatment. Of those who did become infected, two equal-sized, highly matched groups (one that used ivermectin as a prophylaxis and one that did not) were compared. The regular use of preventative ivermectin led to a 68% reduction in COVID-19 mortality (0.8% versus 2.6%), and a 56% reduction in hospitalization rate (1.6% versus 3.3%).
Since vaccines were not available at the time, and few prophylactic alternatives existed in the absence of vaccines, Itajaí initiated a population-wide government program for COVID-19 prophylaxis. This was a prospective observational study that allowed subjects to self-select between treatment vs. non-treatment. The use of ivermectin was optional and based on patients’ preferences, given its benefits as a preventative agent was unproven.
To ensure the safety of the population, a computer program was developed to compile and maintain all relevant demographic and clinical data. All subjects were weighed to be able to accurately calculate the correct dose of ivermectin. In addition, a brief medical evaluation was conducted to record past medical history, comorbidities, use of medications and contraindications to drugs.
The following variables were analyzed and adjusted as confounding factors or used for balancing and matching groups for propensity score matching:
Age
Sex
Previous diseases (myocardial infarction and stroke)
Pre-existing comorbidities (type 2 diabetes, asthma, chronic obstructive pulmonary disease, hypertension, dyslipidemia, cardiovascular diseases, cancer [any type], and other pulmonary diseases)
Smoking
Patients who presented signs or the diagnosis of COVID-19 before July 7, 2020, were excluded from the sample. Other exclusion criteria included contraindications to ivermectin and age (subjects below 18 years of age were excluded).
During the study, subjects who were diagnosed with COVID-19 underwent a specific medical visit to assess clinical manifestations and disease severity. All subjects with symptoms were recommended not to use ivermectin, nitazoxanide, hydroxychloroquine, spironolactone, or any other drug claimed to be effective against COVID-19. The city did not provide or support any specific pharmacological outpatient treatment for subjects infected with COVID-19.
Interestingly, the group who self-selected to take ivermectin was older and had more comorbidities than the group who opted for no treatment. These results show that prophylactic ivermectin may be a mitigating factor in groups with higher risk of morbidity.
The results show prophylactic ivermectin may be a mitigating factor for high-risk groups.
The belief that preventative and early treatment therapies would cause people to relax their caution of remaining socially distanced, leading to more COVID-19-related infections, is not supported here.
The data demonstrate that using preventative ivermectin significantly lowers the infection rate, and that benefits outweigh the speculated increased risk of changes in social behaviors.
Brazilian ivermectin,,,
Good Job Guys!
Bravo.
.
P
Invermectin works - but there is ZERO chance you will be able to get it freely in the USA.
Why? Because we have a government-controlled, top-down, corrupt, politicized health care system.
Don’t fear single-payer healthcare - ‘cause its already here.
I know what you mean, but there are still places to get Ivermectin.
Here’s the link to find appointments and pharmacies.
Is there an intelligently done study comparing the death rate of those who used precautionary Ivermectin with those who took two doses of the vaccine?
Works for me
I was sure he told me early on in the pandemic that ivermectin may work.
Our gummit is trying to kill you by denying Ivermectin.
Ivermectin is most effective EARLY in the Covid disease cycle.
Best to apply it within 5 to 6 days at onset of Covid symptoms.
The moment a patient is in ICU, the efficacy is MIXED. Although I have read of several cases of miraculous recoveries, the most recent one, a father who visited his daughter from Hongkong.
The same is true of Hydroxychloroquine.
Talk to the doctors treating their patients... the emphasis is always EARLY TREATMENT.
So, an ICU doctor isn’t going to see good performance on his patients.
I just had it, took Ivermectin every day for 5 days at the onset of symptoms. Stayed home, felt like a mildish case of the flu. Both my wife and I recovered with no problems. I even have type 2 diabetes. Cost me about $600 for both of our Ivermectin prescriptions because of greedy pharmacies, but I paid it anyways. It should have cost about $0.03 a pill instead of $9.
Large, peer-reviewed research study proves Ivermectin works: Regular use of ivermectin as a prophylactic was associated with significantly reduced COVID-19 infection, hospitalization and mortality rates
If public health would be their main concern, by now they would be pushing just about anything and everything which shows any kind of promise along with alternate methods in order to curtail and get a handle on this Chinese virus. So far, many people have scoffed at the idea that this whole scheme is to cull the public and while they are at it make as much profit as possible. However, the way this fight against this Chinese virus is approached, everything points into the opposite direction, which is to restrict and muzzle any kind of promising treatment or information which may help and may be instrumental to eradicate his crappy virus.
“ Totally fake, b.s. study because gas.dr says Ivermectin doesn’t work. ”
Ole gas_bag has likely killed many patients. I’ve asked him/her how many they have lost but they refuse to provide the numbers. It will be interesting to watch the pivot, as gas_bag did (rightly) promote Regeneron (monoclonal antibodoes) which have now been banned.
Ok, gas.dr may have admitted a positive early effect for Ivermectin but overall his implication is that it is not effective.
Yeah sure, vitamin I is not going to rescue one from death’s door, but to suggest that it doesn’t work when in an ICU is stupid (and also not true as sometimes it does).
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.